Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT01706731
Other study ID # 918
Secondary ID
Status Not yet recruiting
Phase N/A
First received October 8, 2012
Last updated October 12, 2012
Start date October 2012
Est. completion date October 2013

Study information

Verified date October 2012
Source Chiang Mai University
Contact Nahathai - Wongpakaran, M.D.
Phone +66 53 945422
Email nkuntawo@med.cmu.ac.th
Is FDA regulated No
Health authority Thailand: Ethical Committee
Study type Interventional

Clinical Trial Summary

This research is to study the effectiveness of cognitive behavioral therapy-CBT and Psychotherapy by trained buddhist monks. There are generally accepted that both cognitive and Buddhist concepts are related. This randomized controlled trial is to study the elderly participants who suffer major depressive disorder according to DSM-IV. The subjects will be divided into two groups. The experimental group will receive 12 sessions of CBT 2 times per week for 6 weeks in addition to usual treatment. The control group will receive treatment as usual and general conversation (non-CBT) with monks. Pretreatment factors (such as attachment style, interpersonal factors) of both therapist monks and patient participants will be studied.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 62
Est. completion date October 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 60 Years to 95 Years
Eligibility Inclusion Criteria:

- Meet criteria for Major depressive disorder

- receiving antidepressant

Exclusion Criteria:

- presence of intense suicidal intent behaviors that require inpatient admission

- history of alcohol or drug dependence

- presence of hallucinations or delusions

- currently receiving electroconvulsive therapy or repetitive-transcranial magnetic stimulation,

- patients' involvement in other clinical trials.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Intervention

Behavioral:
Treatment as usual
Treatment as usual (TAU)is defined as the routine care provided to each individual patient at the geriatric psychiatry clinic of Maharaj Nakorn Chiang Mai Hospital.
Cognitive-behavioral therapy
Cognitive behavioral therapy(CBT)includes psychoeducational components combined with cognitive interventions targeted at challenging negative automatic thoughts.

Locations

Country Name City State
Thailand Geriatric clinic, Maharaj Nakorn Chiang Mai Hospital Chiang Mai

Sponsors (1)

Lead Sponsor Collaborator
Chiang Mai University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Other working alliance Working alliance will be assessed by the Helping Alliance Questionnaire (HAQ)(Luborsky, 1996) after session 3, 6, and 12 No
Other Pretreatment measure (attachment) The part includes participants' attachment which will be assessed by the revised Experience of Close Relationships Questionnaire (ECR-R 18)(Wongpakaran, 2012) at baseline No
Other Pretreatment measure (interpersonal problems) Interpersonal problems will be assessed by the inventory of interpersonal problems(Horowitz, 2000) at baseline No
Other Pretreatment measure(neuroticism) Neuroticism will be assessed by the Neuroticsm Inventory (Wongpakaran,unpublished) at baseline No
Primary Evidence of clinically depression confirmed by clinician Depression will be assessed by HAMD-7 (McIntyre, 2005) 2 months after the end of the intervention No
Primary Depression- self report depression will be assessed by Geriatric Depression Scale (GDS)(Shiekh & Yesavage, 1986) 2 month after the end of the inetrvention No
Secondary Dimensional psychological distress (anxiety, depression,and somatization) anxiety, depression,and somatization symptom will be assessed by the Core symptom index (CSI) (Wongpakaran, unpublished), week 6, 12, 20 No
Secondary Dimensional psychological distress ( perception of stress) Perception of stress will be assessed by Perceived Stress Scale-10 (PSS-10) (Cohen 1983 ; Wongpakaran, 2010) Week 6, 12, 20 No
See also
  Status Clinical Trial Phase
Recruiting NCT05537558 - Precision Medicine for the Prediction of Treatment (PROMPT) Response (PROMPT)
Terminated NCT02192099 - Open Label Extension for GLYX13-C-202, NCT01684163 Phase 2
Completed NCT03142919 - Lipopolysaccharide (LPS) Challenge in Depression Phase 2
Recruiting NCT05547035 - Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders N/A
Terminated NCT02940769 - Neurobiological Effects of Light on MDD N/A
Recruiting NCT05892744 - Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression Phase 4
Recruiting NCT05537584 - SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Phase 4
Active, not recruiting NCT05061706 - Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder Phase 3
Completed NCT04479852 - A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder Phase 2
Recruiting NCT04032301 - Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans Phase 1
Recruiting NCT05527951 - Enhanced Measurement-Based Care Effectiveness for Depression (EMBED) Study N/A
Completed NCT03511599 - Cycloserine rTMS Plasticity Augmentation in Depression Phase 1
Recruiting NCT04392947 - Treatment of Major Depressive Disorder With Bilateral Theta Burst Stimulation N/A
Recruiting NCT05895747 - 5-HTP and Creatine for Depression R33 Phase Phase 2
Recruiting NCT05273996 - Predictors of Cognitive Outcomes in Geriatric Depression Phase 4
Recruiting NCT05813093 - Interleaved TMS-fMRI in Ultra-treatment Resistant Depression N/A
Recruiting NCT05135897 - The Neurobiological Fundaments of Depression and Its Relief Through Neurostimulation Treatments
Enrolling by invitation NCT04509102 - Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder Early Phase 1
Recruiting NCT06145594 - EMA-Guided Maintenance TMS for Depression N/A
Recruiting NCT06026917 - Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET) Phase 4